This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
| bigram | frequency |
|---|---|
| virus infection | 276 |
| infected cells | 235 |
| united states | 201 |
| respiratory tract | 192 |
| respiratory syndrome | 164 |
| acute respiratory | 153 |
| type i | 147 |
| influenza virus | 146 |
| respiratory viruses | 140 |
| viral infection | 132 |
| amino acid | 131 |
| viral rna | 128 |
| respiratory syncytial | 128 |
| mycoplasma pneumoniae | 125 |
| immune response | 121 |
| viral infections | 119 |
| antibiotic resistance | 119 |
| host cell | 118 |
| syncytial virus | 118 |
| rna viruses | 115 |
| virus replication | 110 |
| endoplasmic reticulum | 107 |
| viral replication | 107 |
| filamentous phage | 105 |
| immune responses | 100 |
| zika virus | 99 |
| dengue virus | 96 |
| epithelial cells | 95 |
| antimicrobial peptides | 94 |
| core protein | 93 |
| host cells | 92 |
| lower respiratory | 91 |
| innate immune | 91 |
| front microbiol | 89 |
| cord uid | 89 |
| microbiol doi | 89 |
| doc id | 89 |
| ms plp | 88 |
| stem cell | 83 |
| membrane fusion | 83 |
| vero cells | 82 |
| hcv core | 82 |
| gene expression | 82 |
| severe acute | 82 |
| cell culture | 80 |
| antiviral activity | 80 |
| tract infections | 77 |
| cell lines | 76 |
| i ifn | 76 |
| respiratory viral | 76 |
| time pcr | 75 |
| nucleic acid | 75 |
| respiratory virus | 72 |
| amino acids | 72 |
| virus infections | 72 |
| immune system | 71 |
| capsid protein | 71 |
| cell transplant | 70 |
| syndrome virus | 69 |
| measles virus | 69 |
| signaling pathway | 68 |
| human metapneumovirus | 67 |
| porcine epidemic | 67 |
| cell line | 66 |
| supplementary table | 66 |
| infectious diseases | 65 |
| signaling pathways | 65 |
| performed using | 64 |
| strain srs | 64 |
| transplant recipients | 64 |
| porcine reproductive | 64 |
| syndrome coronavirus | 63 |
| viral proteins | 63 |
| hela cells | 62 |
| zikv infection | 62 |
| epidemic diarrhea | 62 |
| innate immunity | 62 |
| disease virus | 61 |
| previously described | 61 |
| parainfluenza virus | 61 |
| cell transplantation | 61 |
| public health | 60 |
| life cycle | 60 |
| respiratory infections | 60 |
| significantly higher | 60 |
| cell cycle | 59 |
| nlrp inflammasome | 59 |
| cell fusion | 59 |
| orf protein | 58 |
| herpes simplex | 58 |
| mg kg | 58 |
| genome sequence | 58 |
| monoclonal antibody | 57 |
| supplementary material | 56 |
| er stress | 55 |
| diarrhea virus | 55 |
| protein expression | 55 |
| lipid rafts | 55 |
| barr virus | 54 |
| risk factors | 54 |
| viral entry | 53 |
| simplex virus | 53 |
| virus type | 53 |
| stranded rna | 52 |
| present study | 52 |
| hematopoietic cell | 52 |
| human adenovirus | 51 |
| previous studies | 51 |
| positively selected | 51 |
| hematopoietic stem | 50 |
| human rhinovirus | 49 |
| expression levels | 49 |
| viral protein | 49 |
| target cells | 49 |
| acquired pneumonia | 49 |
| ifn signaling | 48 |
| intracellular extracts | 47 |
| statistically significant | 47 |
| hct recipients | 47 |
| results showed | 47 |
| cellular proteins | 47 |
| respiratory pathogens | 46 |
| positive selection | 46 |
| host proteins | 46 |
| hpv psv | 45 |
| viral load | 45 |
| cells infected | 45 |
| pdcov hnzk | 44 |
| swine fever | 44 |
| important role | 44 |
| antimicrobial peptide | 43 |
| clinical samples | 43 |
| protein kinase | 43 |
| multiplex pcr | 43 |
| viral particles | 43 |
| viral genome | 43 |
| target cell | 43 |
| fever virus | 42 |
| crystal structure | 42 |
| control group | 42 |
| cell surface | 41 |
| neutralizing antibodies | 41 |
| cell membrane | 41 |
| ebola virus | 41 |
| described previously | 41 |
| type iii | 41 |
| three times | 41 |
| morpholino oligomers | 41 |
| structural proteins | 40 |
| mammalian cells | 40 |
| immunodeficiency virus | 40 |
| plasma membrane | 40 |
| cells treated | 40 |
| phylogenetic analysis | 39 |
| genetic diversity | 39 |
| mass spectrometry | 39 |
| microbiology www | 39 |
| selected sites | 39 |
| clinical signs | 39 |
| mouth disease | 39 |
| encephalitis virus | 39 |
| reverse transcription | 39 |
| binding protein | 38 |
| room temperature | 38 |
| unfolded protein | 38 |
| financial relationships | 38 |
| atmuv infection | 38 |
| phage display | 38 |
| aa identity | 38 |
| thermo fisher | 38 |
| ifitm proteins | 38 |
| growth factor | 38 |
| virus entry | 38 |
| protein response | 38 |
| novel coronavirus | 37 |
| segmented filamentous | 37 |
| coat protein | 37 |
| potential conflict | 37 |
| virus core | 37 |
| testicular tissue | 37 |
| bluefin tuna | 37 |
| clinical trials | 37 |
| pedv infection | 37 |
| cultured cells | 37 |
| selective pressure | 36 |
| genome sequences | 36 |
| pneumoniae infection | 36 |
| respiratory infection | 36 |
| lung injury | 36 |
| human immunodeficiency | 36 |
| filamentous bacteria | 36 |
| african swine | 36 |
| ma sr | 36 |
| open reading | 36 |
| pcr assay | 35 |
| antimicrobial resistance | 35 |
| rna virus | 35 |
| rna polymerase | 35 |
| sgh symptoms | 35 |
| found online | 35 |
| total rna | 35 |
| expressing cells | 35 |
| fisher scientific | 35 |
| fmdv infection | 35 |
| recent study | 35 |
| gut microbiota | 35 |
| negative control | 35 |
| coronavirus disease | 34 |
| results suggest | 34 |
| viral pathogenesis | 34 |
| closely related | 34 |
| authors declare | 34 |
| induced asthma | 34 |
| spike protein | 34 |
| dependent manner | 34 |
| cell death | 33 |
| resistance genes | 33 |
| dendritic cells | 33 |
| neutralizing antibody | 33 |
| cell entry | 33 |
| previous study | 33 |
| membrane protein | 33 |
| heavy metal | 33 |
| copy number | 32 |
| mrna expression | 32 |
| envelope protein | 32 |
| whole genome | 32 |
| cells via | 32 |
| er membrane | 32 |
| inflammatory cytokines | 32 |
| generation sequencing | 31 |
| upper respiratory | 31 |
| recent studies | 31 |
| sequence analysis | 31 |
| eta ds | 31 |
| reading frame | 31 |
| capsid proteins | 31 |
| escherichia coli | 31 |
| monoclonal antibodies | 31 |
| mcp complex | 30 |
| endothelial cells | 30 |
| independent experiments | 30 |
| three independent | 30 |
| antiviral therapy | 30 |
| associated degradation | 30 |
| rna species | 30 |
| adenovirus type | 30 |
| western blot | 30 |
| transcription factor | 30 |
| inflammatory response | 30 |
| dna vaccine | 30 |
| pdcov infection | 29 |
| simultaneous detection | 29 |
| animal models | 29 |
| original author | 29 |
| social norms | 29 |
| full supplementary | 29 |
| chain reaction | 29 |
| rna replication | 29 |
| creative commons | 29 |
| commons attribution | 29 |
| cdv infection | 29 |
| polymerase chain | 29 |
| respiratory disease | 29 |
| attribution license | 29 |
| bat species | 29 |
| human health | 29 |
| original publication | 29 |
| rk cells | 29 |
| article distributed | 29 |
| coding genes | 29 |
| sendai virus | 29 |
| org articles | 28 |
| bovine serum | 28 |
| adult patients | 28 |
| host immune | 28 |
| well plate | 28 |
| mediated endocytosis | 28 |
| significant differences | 28 |
| data analysis | 28 |
| porcine circovirus | 28 |
| cancer cells | 28 |
| may also | 28 |
| like lineage | 28 |
| accepted academic | 28 |
| academic practice | 28 |
| western blotting | 28 |
| disease severity | 28 |
| human respiratory | 28 |
| host innate | 28 |
| clinical symptoms | 27 |
| stress granules | 27 |
| goat anti | 27 |
| transmembrane protein | 27 |
| wild type | 27 |
| filamentous bacteriophage | 27 |
| lu cells | 27 |
| hemorrhagic fever | 27 |
| mcp endocytosis | 27 |
| hospitalized patients | 27 |
| genomic dna | 27 |
| antimicrobial activity | 27 |
| canine distemper | 27 |
| associated herpesvirus | 27 |
| systematic review | 27 |
| significantly increased | 27 |
| luciferase reporter | 27 |
| time points | 27 |
| vigen pipeline | 27 |
| treated mice | 27 |
| clinical specimens | 26 |
| body sites | 26 |
| viral pneumonia | 26 |
| i interferon | 26 |
| well plates | 26 |
| hrv infection | 26 |
| pcv replication | 26 |
| days post | 26 |
| infected mice | 26 |
| japanese encephalitis | 26 |
| aurintricarboxylic acid | 26 |
| transfected cells | 26 |
| pneumoniae infections | 26 |
| significant difference | 26 |
| cell proliferation | 26 |
| taken together | 26 |
| signal transduction | 26 |
| binding site | 26 |
| sars coronavirus | 26 |
| gel electrophoresis | 25 |
| hev infection | 25 |
| low ph | 25 |
| west nile | 25 |
| global health | 25 |
| tract infection | 25 |
| cell receptor | 25 |
| body weight | 25 |
| tgev group | 25 |
| hr domain | 25 |
| rapid detection | 25 |
| different types | 25 |
| access article | 25 |
| streptococcus pneumoniae | 25 |
| statistical significance | 25 |
| structural protein | 25 |
| glycogen synthase | 25 |
| large number | 25 |
| ppmo targeting | 25 |
| better understanding | 25 |
| porcine deltacoronavirus | 25 |
| stat signaling | 25 |
| electron microscopy | 25 |
| middle east | 25 |
| molecular mechanisms | 25 |
| copies ml | 25 |
| human papillomavirus | 25 |
| isothermal amplification | 25 |
| lymphocytic choriomeningitis | 25 |
| nile virus | 25 |
| viral dna | 25 |
| xmap technology | 25 |
| cervical cancer | 25 |
| data suggest | 24 |
| hcv replication | 24 |
| stress granule | 24 |
| agarose gel | 24 |
| hpv infection | 24 |
| molecular epidemiology | 24 |
| acid residues | 24 |
| plasmodium falciparum | 24 |
| microbial communities | 24 |
| sense rna | 24 |
| choriomeningitis virus | 24 |
| human coronavirus | 24 |
| virus particles | 24 |
| one health | 24 |
| gut microbiome | 24 |
| bal ds | 24 |
| pr pbs | 24 |
| allogeneic hematopoietic | 23 |
| coronavirus infection | 23 |
| genome sequencing | 23 |
| intensive care | 23 |
| also known | 23 |
| analyzed using | 23 |
| class i | 23 |
| previous reports | 23 |
| avian influenza | 23 |
| immune cells | 23 |
| flow cytometry | 23 |
| cell types | 23 |
| inhibitory activity | 23 |
| tissue culture | 23 |
| protein synthesis | 23 |
| circovirus type | 23 |
| nonstructural protein | 23 |
| tgev infection | 23 |
| east respiratory | 23 |
| nucleotide sequences | 23 |
| secondary scaffolding | 23 |
| phage displaying | 23 |
| pbs group | 23 |
| heavy metals | 23 |
| genomic rna | 23 |
| penton base | 22 |
| economic losses | 22 |
| ns protein | 22 |
| enveloped viruses | 22 |
| respiratory symptoms | 22 |
| least one | 22 |
| highly conserved | 22 |
| high mannose | 22 |
| inflammasome activation | 22 |
| chronic pain | 22 |
| determined using | 22 |
| widely used | 22 |
| distemper virus | 22 |
| inhibitory effect | 22 |
| two groups | 22 |
| viral pathogens | 22 |
| polyclonal antibody | 22 |
| dna replication | 22 |
| cancer patients | 22 |
| mrna levels | 22 |
| inflammatory cytokine | 22 |
| differentially expressed | 22 |
| polyclonal antibodies | 22 |
| synthase kinase | 22 |
| positively charged | 22 |
| time rt | 22 |
| may lead | 22 |
| southern bluefin | 22 |
| dependent endocytosis | 22 |
| virus ns | 22 |
| human parainfluenza | 21 |
| th cells | 21 |
| induced apoptosis | 21 |
| way anova | 21 |
| rna genome | 21 |
| determine whether | 21 |
| dependent rna | 21 |
| recent years | 21 |
| cell viability | 21 |
| gs cells | 21 |
| commercially available | 21 |
| host factor | 21 |
| rhinovirus infection | 21 |
| mediated isothermal | 21 |
| serratia marcescens | 21 |
| like receptor | 21 |
| bacterial pathogens | 21 |
| severe disease | 21 |
| nucleic acids | 21 |
| infected patients | 21 |
| control cells | 21 |
| previously reported | 21 |
| microbial community | 21 |
| fetal bovine | 21 |
| world health | 21 |
| human igg | 21 |
| persistent infection | 21 |
| young children | 21 |
| vitro prophylactic | 21 |
| ion channel | 20 |
| viral genomes | 20 |
| mg ml | 20 |
| copyright owner | 20 |
| vesicular stomatitis | 20 |
| transmissible gastroenteritis | 20 |
| culture supernatants | 20 |
| highly pathogenic | 20 |
| viral diseases | 20 |
| mesenteroides ypk | 20 |
| avian leukosis | 20 |
| microbial diversity | 20 |
| mouse model | 20 |
| sequence similarity | 20 |
| bacterial infections | 20 |
| another study | 20 |
| ifn production | 20 |
| epithelial cell | 20 |
| molecular evolution | 20 |
| adaptive immune | 20 |
| virus orf | 20 |
| final concentration | 20 |
| socs expression | 20 |
| expression level | 20 |
| lactic acid | 20 |
| iav infection | 20 |
| displaying pep | 20 |
| capsid coat | 20 |
| statistical analysis | 20 |
| health organization | 20 |
| leukosis virus | 20 |
| severe covid | 20 |
| antibody response | 20 |
| proteomic analysis | 20 |
| hek cells | 19 |
| subcellular localization | 19 |
| common cold | 19 |
| salivary gland | 19 |
| blood fluke | 19 |
| high levels | 19 |
| commonly used | 19 |
| caveolae raft | 19 |
| significantly reduced | 19 |
| stomatitis virus | 19 |
| ubiquitin ligase | 19 |
| detection rate | 19 |
| homologous recombination | 19 |
| cells using | 19 |
| among different | 19 |
| viral titers | 19 |
| significantly different | 19 |
| protein folding | 19 |
| accession number | 19 |
| liver cancer | 19 |
| also found | 19 |
| clinical trial | 19 |
| immune evasion | 19 |
| macro domain | 19 |
| luciferase activity | 19 |
| envelope glycoprotein | 19 |
| late stage | 19 |
| complete genome | 19 |
| binding domain | 19 |
| reticulum stress | 19 |
| associated protein | 19 |
| years ago | 19 |
| terminal region | 19 |
| clinical features | 19 |
| assay kit | 19 |
| mock group | 19 |
| acid bacteria | 18 |
| critical role | 18 |
| phylogenetic trees | 18 |
| like growth | 18 |
| fusion protein | 18 |
| different time | 18 |
| common respiratory | 18 |
| igf mrna | 18 |
| infected individuals | 18 |
| sap mutant | 18 |
| mortality rate | 18 |
| genome replication | 18 |
| viral detection | 18 |
| quality control | 18 |
| treated cells | 18 |
| binding sites | 18 |
| psv entry | 18 |
| pcr amplification | 18 |
| virus detection | 18 |
| respiratory distress | 18 |
| rabbit polyclonal | 18 |
| homing peptide | 18 |
| human norovirus | 18 |
| nervous system | 18 |
| rrna gene | 18 |
| receptor binding | 18 |
| gastrointestinal tract | 18 |
| specific primers | 18 |
| antiviral effects | 18 |
| pcv infection | 18 |
| genotype hev | 18 |
| virus envelope | 18 |
| among patients | 18 |
| also shown | 17 |
| infection control | 17 |
| initiation factor | 17 |
| distress syndrome | 17 |
| virus rna | 17 |
| viral capsid | 17 |
| vaccinia virus | 17 |
| reverse transcriptase | 17 |
| dna viruses | 17 |
| pr infection | 17 |
| orf product | 17 |
| gsk inhibition | 17 |
| infection rate | 17 |
| lung tissue | 17 |
| rhesus macaques | 17 |
| antiviral responses | 17 |
| several studies | 17 |
| sequence alignment | 17 |
| viral envelope | 17 |
| day post | 17 |
| mosquito cells | 17 |
| viral lineages | 17 |
| natural ecosystems | 17 |
| life technologies | 17 |
| induced transmembrane | 17 |
| serratia sp | 17 |
| nipah virus | 17 |
| molecular biology | 17 |
| like particles | 17 |
| tembusu virus | 17 |
| virus capsid | 17 |
| multiplex detection | 17 |
| causative agent | 17 |
| hcv rna | 17 |
| publicly available | 17 |
| pcr system | 17 |
| cholera toxin | 17 |
| hev replication | 17 |
| pdb id | 17 |
| virus nonstructural | 17 |
| infectious bronchitis | 17 |
| tumor cells | 17 |
| ms ms | 17 |
| er lumen | 17 |
| iso ts | 17 |
| viral gene | 17 |
| family members | 17 |
| human cytomegalovirus | 17 |
| host factors | 17 |
| antibody responses | 17 |
| acid substitutions | 17 |
| sequence data | 17 |
| drug resistance | 17 |
| proteins may | 17 |
| expression plasmid | 16 |
| protein levels | 16 |
| phylogenetic tree | 16 |
| gpsghv infection | 16 |
| activated protein | 16 |
| results obtained | 16 |
| kindly provided | 16 |
| overt sgh | 16 |
| coat proteins | 16 |
| pr ppp | 16 |
| high risk | 16 |
| rubella virus | 16 |
| wide range | 16 |
| human bocavirus | 16 |
| human host | 16 |
| current study | 16 |
| infectious disease | 16 |
| insect cells | 16 |
| pathogenic viruses | 16 |
| peptides derived | 16 |
| misfolded proteins | 16 |
| gene transfer | 16 |
| interferon production | 16 |
| common ancestor | 16 |
| results suggested | 16 |
| applied biosystems | 16 |
| kefir grains | 16 |
| bioactive compounds | 16 |
| ifitm expression | 16 |
| disease control | 16 |
| virus release | 16 |
| secondary antibody | 16 |
| tm system | 16 |
| intestinal epithelial | 16 |
| different concentrations | 16 |
| among children | 16 |
| hospitalized children | 16 |
| patients infected | 16 |
| mutant fmdv | 16 |
| denv infection | 16 |
| linked immunosorbent | 16 |
| molecular epidemiological | 16 |
| stranded dna | 16 |
| material key | 16 |
| also observed | 16 |
| xtag rvp | 16 |
| pcv orf | 16 |
| calculated using | 16 |
| mucosal microbiome | 16 |
| ge healthcare | 16 |
| mapk signaling | 16 |
| fusion core | 16 |
| cell cultures | 16 |
| transmembrane proteins | 16 |
| authors contributed | 16 |
| seq data | 16 |
| comparative analysis | 16 |
| coat related | 16 |
| hev strains | 16 |
| cytokine storm | 16 |
| virus strains | 16 |
| encephalomyocarditis virus | 16 |
| wide variety | 16 |
| multiplex assays | 16 |
| melanoma cells | 16 |
| buffered saline | 15 |
| detected using | 15 |
| duck ifitm | 15 |
| scaff link | 15 |
| human coronaviruses | 15 |
| fused cells | 15 |
| intestinal microbiota | 15 |
| pulmonary disease | 15 |
| nasopharyngeal carcinoma | 15 |
| datasets generated | 15 |
| cellular receptor | 15 |
| stimulated genes | 15 |
| antibacterial activity | 15 |
| one study | 15 |
| new york | 15 |
| human igm | 15 |
| nucleolar localization | 15 |
| viral respiratory | 15 |
| steroid use | 15 |
| cell membranes | 15 |
| nitric oxide | 15 |
| bronchitis virus | 15 |
| cell wall | 15 |
| sars cov | 15 |
| prospective study | 15 |
| env protein | 15 |
| major capsid | 15 |
| tumor mass | 15 |
| structural basis | 15 |
| target sequence | 15 |
| metabolic syndrome | 15 |
| gland hypertrophy | 15 |
| infection induces | 15 |
| overall mortality | 15 |
| also identified | 15 |
| viral shedding | 15 |
| virus adsorption | 15 |
| infectious agents | 15 |
| hantaan virus | 15 |
| genome size | 15 |
| igf protein | 15 |
| three different | 15 |
| associated proteins | 15 |
| rsv infection | 15 |
| even though | 15 |
| egr sirna | 15 |
| pediatric patients | 15 |
| virus strain | 15 |
| disease progression | 15 |
| hev genotypes | 15 |
| positive samples | 15 |
| batcov hku | 15 |
| lcmv infection | 15 |
| transcriptional activity | 15 |
| antibiotic use | 15 |
| mm nacl | 15 |
| food safety | 15 |
| highly effective | 15 |
| essential role | 15 |
| endophytic fungi | 15 |
| gold standard | 15 |
| turnaround time | 15 |
| severe respiratory | 15 |
| graphpad prism | 15 |
| bat origin | 15 |
| transmembrane domain | 15 |
| serratia species | 15 |
| sequence identity | 15 |
| vp region | 15 |
| organ transplant | 15 |
| diagnostic methods | 15 |
| qpcr detection | 15 |
| iseq tm | 15 |
| immunosorbent assay | 15 |
| mouse igg | 15 |
| culture system | 15 |
| internal control | 15 |
| clinical characteristics | 15 |
| may provide | 15 |
| antiviral immunity | 15 |
| multiple sequence | 15 |
| also detected | 15 |
| extraction efficiency | 15 |
| glycosylation sites | 15 |
| infected host | 15 |
| analysis showed | 15 |
| new insights | 15 |
| induced cell | 15 |
| insulin resistance | 14 |
| antiviral innate | 14 |
| asthma exacerbations | 14 |
| breast cancer | 14 |
| results indicated | 14 |
| virion assembly | 14 |
| lysis buffer | 14 |
| cbdi genomes | 14 |
| chronic hepatitis | 14 |
| respiratory illness | 14 |
| peripheral blood | 14 |
| rna extraction | 14 |
| infected cell | 14 |
| nh cl | 14 |
| regulatory factor | 14 |
| may cause | 14 |
| positive control | 14 |
| like receptors | 14 |
| cells pretreated | 14 |
| important roles | 14 |
| hev rna | 14 |
| pr igf | 14 |
| nucleotide sequence | 14 |
| active site | 14 |
| incubated overnight | 14 |
| treatment group | 14 |
| jurkat cells | 14 |
| vp protein | 14 |
| submitted version | 14 |
| enteric rna | 14 |
| human cells | 14 |
| mm tris | 14 |
| medius genome | 14 |
| aptamer cy | 14 |
| rhesus monkeys | 14 |
| resistant bacteria | 14 |
| informed consent | 14 |
| pseudomonas aeruginosa | 14 |
| two different | 14 |
| target genes | 14 |
| hemorrhagic disease | 14 |
| two distinct | 14 |
| rna synthesis | 14 |
| translation initiation | 14 |
| four farms | 14 |
| metabolic activity | 14 |
| literature review | 14 |
| cell apoptosis | 14 |
| adenovirus infection | 14 |
| quantitative pcr | 14 |
| phylogenetic diversity | 14 |
| fish species | 14 |
| nuclear translocation | 14 |
| nuclear localization | 14 |
| reactive oxygen | 14 |
| antiviral response | 14 |
| dna virus | 14 |
| cellular processes | 14 |
| quantitative real | 14 |
| infection induced | 14 |
| entry efficiency | 14 |
| human adenoviruses | 14 |
| converting enzyme | 14 |
| host range | 14 |
| infected group | 14 |
| rna binding | 14 |
| viral loads | 14 |
| gastroenteritis virus | 14 |
| wildtype fmdv | 14 |
| antiviral agents | 14 |
| study showed | 14 |
| cellular uptake | 14 |
| mouse anti | 14 |
| enrichment analysis | 14 |
| kosakovsky pond | 14 |
| virus genome | 14 |
| tract disease | 14 |
| age group | 14 |
| pathogenic bacteria | 14 |
| pcr analysis | 14 |
| dna extraction | 14 |
| cytopathic effect | 14 |
| nucleocapsid protein | 14 |
| virus subgroup | 14 |
| viral variants | 13 |
| beta diversity | 13 |
| fungal pathogens | 13 |
| washed three | 13 |
| secondary structure | 13 |
| inhibitory effects | 13 |
| virus titer | 13 |
| morpholino oligomer | 13 |
| conjugated morpholino | 13 |
| respiratory diseases | 13 |
| healthy controls | 13 |
| respiratory specimens | 13 |
| viral genes | 13 |
| lassa virus | 13 |
| sequencing data | 13 |
| proteasomal degradation | 13 |
| mesenteroides subsp | 13 |
| pzq treatment | 13 |
| high prevalence | 13 |
| transcription factors | 13 |
| unusual viral | 13 |
| lr union | 13 |
| syncytium formation | 13 |
| secondary antibodies | 13 |
| health care | 13 |
| mrna splicing | 13 |
| like protein | 13 |
| cells well | 13 |
| high throughput | 13 |
| ethics committee | 13 |
| ng ml | 13 |
| genetic analysis | 13 |
| analysis revealed | 13 |
| cell receptors | 13 |
| human herpesvirus | 13 |
| akt signaling | 13 |
| nuclear antigen | 13 |
| infected samples | 13 |
| fluorescent signal | 13 |
| like protease | 13 |
| host cellular | 13 |
| hcv genotypes | 13 |
| remains unclear | 13 |
| antiviral signaling | 13 |
| mechanisms underlying | 13 |
| innate antiviral | 13 |
| mediated antiviral | 13 |
| north america | 13 |
| also showed | 13 |
| animal model | 13 |
| cells expressing | 13 |
| also called | 13 |
| detection probes | 13 |
| evolutionary analysis | 13 |
| rv species | 13 |
| drug delivery | 13 |
| rapid diagnosis | 13 |
| proteins involved | 13 |
| analysis using | 13 |
| tsetse fly | 13 |
| granule formation | 13 |
| long time | 13 |
| protein degradation | 13 |
| meyer sauteur | 13 |
| pcr products | 13 |
| norovirus gii | 13 |
| regulated proteins | 13 |
| cysteine protease | 13 |
| hypervariable regions | 13 |
| mammalian cell | 13 |
| uninfected cells | 13 |
| antiviral immune | 13 |
| swine industry | 13 |
| hydroxyphthalic anhydride | 13 |
| infection rates | 13 |
| host defense | 13 |
| sexual transmission | 13 |
| dna polymerase | 13 |
| relatively low | 13 |
| iii ifns | 13 |
| microbiome composition | 13 |
| erad substrates | 13 |
| human gut | 13 |
| empty vector | 13 |
| viral infectivity | 13 |
| sequence reads | 13 |
| genbank accession | 13 |
| rabbit hemorrhagic | 13 |
| serum samples | 13 |
| potential targets | 13 |
| van der | 13 |
| envelope glycoproteins | 13 |
| final manuscript | 13 |
| hcv infection | 13 |
| mice treated | 13 |
| acute hepatitis | 13 |
| drug administration | 13 |
| early stages | 13 |
| mhc class | 13 |
| pedv activity | 13 |
| ifitm genes | 13 |
| bimc assay | 12 |
| cellular protein | 12 |
| gene silencing | 12 |
| recent advances | 12 |
| host interactions | 12 |
| molecular evolutionary | 12 |
| luminex xtag | 12 |
| increased risk | 12 |
| proteins associated | 12 |
| least three | 12 |
| may help | 12 |
| host receptors | 12 |
| community acquired | 12 |
| antiviral function | 12 |
| basement membrane | 12 |
| proteolytic processing | 12 |
| data collection | 12 |
| clinical presentation | 12 |
| nucleocytoplasmic trafficking | 12 |
| cellular proteomes | 12 |
| signal peptidase | 12 |
| tcid ml | 12 |
| pmo targeting | 12 |
| pregnant women | 12 |
| antisense morpholino | 12 |
| intracellular offspring | 12 |
| network analysis | 12 |
| stress response | 12 |
| kidney cells | 12 |
| tumor cell | 12 |
| host antiviral | 12 |
| terminal domain | 12 |
| early stage | 12 |
| orf gene | 12 |
| pathogen panel | 12 |
| mortality rates | 12 |
| genomic analysis | 12 |
| grouper iridovirus | 12 |
| may play | 12 |
| conjugated goat | 12 |
| cohort study | 12 |
| protein translation | 12 |
| genetic elements | 12 |
| data indicate | 12 |
| ifn induction | 12 |
| gene sequences | 12 |
| heavy chain | 12 |
| also reported | 12 |
| protein spots | 12 |
| cells incubated | 12 |
| sequence information | 12 |
| cell signaling | 12 |
| kegg pathway | 12 |
| clinical data | 12 |
| cell growth | 12 |
| obstructive pulmonary | 12 |
| antiviral drug | 12 |
| antiviral drugs | 12 |
| maximum likelihood | 12 |
| airway epithelial | 12 |
| key role | 12 |
| jak stat | 12 |
| assessed using | 12 |
| plant pathogens | 12 |
| recent report | 12 |
| highly variable | 12 |
| strand rna | 12 |
| biological replicates | 12 |
| glossina pallidipes | 12 |
| recently reported | 12 |
| therapeutic potential | 12 |
| control sequence | 12 |
| two types | 12 |
| antibody titers | 12 |
| molecular weight | 12 |
| gene products | 12 |
| savannah river | 12 |
| specific antibody | 12 |
| process control | 12 |
| considered statistically | 12 |
| error bars | 12 |
| cell responses | 12 |
| oxygen species | 12 |
| qlamp assay | 12 |
| actin cytoskeleton | 12 |
| specific control | 12 |
| eta tt | 12 |
| protein abundance | 12 |
| antiviral activities | 12 |
| highly contagious | 12 |
| single nucleotide | 12 |
| specific antibodies | 12 |
| acute wheezing | 12 |
| tumor necrosis | 12 |
| metal resistance | 12 |
| reading frames | 12 |
| quantitative analysis | 12 |
| type ii | 12 |
| swab samples | 12 |
| gpnmb expression | 12 |
| necrosis factor | 12 |
| reporter plasmid | 12 |
| hev genome | 12 |
| sgiv infection | 12 |
| standard deviation | 12 |
| oxidative stress | 12 |
| infected animals | 12 |
| ssrna viruses | 12 |
| epi isl | 12 |
| human polyclonal | 12 |
| human populations | 12 |
| protease activity | 12 |
| drug discovery | 12 |
| pcp domain | 12 |
| tumor growth | 12 |
| influenza viruses | 12 |
| severe influenza | 11 |
| genbank id | 11 |
| stimulated gene | 11 |
| length genome | 11 |
| potential role | 11 |
| pedv rna | 11 |
| rabbit anti | 11 |
| digesta samples | 11 |
| santa cruz | 11 |
| protein interaction | 11 |
| orip binding | 11 |
| protein ns | 11 |
| binding affinity | 11 |
| acute viral | 11 |
| adenovirus species | 11 |
| antiviral effect | 11 |
| chronic infection | 11 |
| coronavirus spike | 11 |
| significantly decreased | 11 |
| acid amplification | 11 |
| herd immunity | 11 |
| eif alpha | 11 |
| protective effect | 11 |
| primer sets | 11 |
| heat shock | 11 |
| alpha beta | 11 |
| antibiotic resistome | 11 |
| cleavage site | 11 |
| clinical settings | 11 |
| frequently detected | 11 |
| igm repertoire | 11 |
| risk hpv | 11 |
| membrane dent | 11 |
| infection may | 11 |
| intraperitoneally injected | 11 |
| van den | 11 |
| porcine respiratory | 11 |
| srs soils | 11 |
| channel activity | 11 |
| standard deviations | 11 |
| hcv life | 11 |
| hepg cells | 11 |
| control rna | 11 |
| time point | 11 |
| membrane dents | 11 |
| measured using | 11 |
| many viruses | 11 |
| results demonstrated | 11 |
| charged region | 11 |
| age groups | 11 |
| strains belonging | 11 |
| different lineages | 11 |
| induced ifn | 11 |
| lr phylo | 11 |
| also revealed | 11 |
| hev orf | 11 |
| bovine beta | 11 |
| class ii | 11 |
| rdrp regions | 11 |
| ppp group | 11 |
| genome copies | 11 |
| knockdown cells | 11 |
| biological processes | 11 |
| cell differentiation | 11 |
| coronavirus infections | 11 |
| nucleotide polymorphisms | 11 |
| virus cell | 11 |
| te mcat | 11 |
| asthmatic patients | 11 |
| inflammatory lung | 11 |
| real time | 11 |
| cells transfected | 11 |
| st cells | 11 |
| fluorescence signal | 11 |
| emerging viruses | 11 |
| allogeneic hct | 11 |
| total number | 11 |
| negatively charged | 11 |
| tgev infected | 11 |
| virus genomes | 11 |
| endothelial cell | 11 |
| similar results | 11 |
| chronic obstructive | 11 |
| per sample | 11 |
| potential therapeutic | 11 |
| fusion inhibitor | 11 |
| first step | 11 |
| causative agents | 11 |
| hpv entry | 11 |
| lactobacillus plantarum | 11 |
| gene ontology | 11 |
| rhinovirus species | 11 |
| serum albumin | 11 |
| hypertrophy virus | 11 |
| cellular response | 11 |
| male mice | 11 |
| like structures | 11 |
| disulfide bonds | 11 |
| years old | 11 |
| polymerase amplification | 11 |
| nasopharyngeal microbiota | 11 |
| current knowledge | 11 |
| macrolide resistance | 11 |
| significant increase | 11 |
| several viruses | 11 |
| ps infection | 11 |
| copy numbers | 11 |
| tested using | 11 |
| human pathogens | 11 |
| recombinase polymerase | 11 |
| resistant genes | 11 |
| acute inflammatory | 11 |
| new coronavirus | 11 |
| human pathogen | 11 |
| emerging infectious | 11 |
| retrospective study | 11 |
| expressing gm | 11 |
| zikv replication | 11 |
| igf receptor | 11 |
| atmuv replication | 11 |
| closely associated | 11 |
| authors read | 11 |
| genomic sequences | 11 |
| ml hg | 11 |
| genetically engineered | 11 |
| blood samples | 11 |
| pcr positive | 11 |
| roll fold | 11 |
| hr domains | 11 |
| gene therapy | 11 |
| test results | 11 |
| emcv infection | 11 |
| growth response | 11 |
| significantly lower | 11 |
| viruses including | 11 |
| puerto rico | 10 |
| viral particle | 10 |
| acquired respiratory | 10 |
| liver tissue | 10 |
| yeast two | 10 |
| health problem | 10 |
| infections caused | 10 |
| dna vaccines | 10 |
| logistic regression | 10 |
| obtained using | 10 |
| conserved among | 10 |
| fmdv replication | 10 |
| phage particle | 10 |
| old piglets | 10 |
| bone marrow | 10 |
| rsv infections | 10 |
| epidemiological study | 10 |
| inducible factor | 10 |
| linked glycosylation | 10 |
| watery diarrhea | 10 |
| wastewater treatment | 10 |
| may contribute | 10 |
| mediated cell | 10 |
| major coat | 10 |
| natural host | 10 |
| may serve | 10 |
| future research | 10 |
| river site | 10 |
| taxonomic assignment | 10 |
| fold higher | 10 |
| late endosomes | 10 |
| microbiota profiles | 10 |
| results indicate | 10 |
| rich region | 10 |
| hr peptides | 10 |
| interferon regulatory | 10 |
| sg proteome | 10 |
| horizontal transfer | 10 |
| xtag gpp | 10 |
| pf malaria | 10 |
| identified proteins | 10 |
| human ace | 10 |
| ebv genome | 10 |
| human primates | 10 |
| serum levels | 10 |
| human hepatitis | 10 |
| virus isolation | 10 |
| recombination events | 10 |
| expression cassette | 10 |
| research question | 10 |
| written informed | 10 |
| entry receptor | 10 |
| nuclear factor | 10 |
| activation molecule | 10 |
| within days | 10 |
| molecular tests | 10 |
| multiple functions | 10 |
| igf group | 10 |
| protein icp | 10 |
| previously published | 10 |
| four different | 10 |
| sybr green | 10 |
| recognition receptors | 10 |
| throughput sequencing | 10 |
| accession numbers | 10 |
| antibiotic treatment | 10 |
| hematologic malignancies | 10 |
| influenza infection | 10 |
| early growth | 10 |
| detection limit | 10 |
| associated pneumonia | 10 |
| incubation period | 10 |
| gene sequence | 10 |
| dn ds | 10 |
| virus genotype | 10 |
| therapeutic strategies | 10 |
| zoonotic viruses | 10 |
| national center | 10 |
| parainfluenza viruses | 10 |
| fusion inhibitors | 10 |
| bacterial co | 10 |
| viral etiology | 10 |
| hev particles | 10 |
| pneumoniae cap | 10 |
| target dna | 10 |
| hepatocellular carcinoma | 10 |
| genome assembly | 10 |
| zikv strains | 10 |
| engineered phage | 10 |
| virus disease | 10 |
| factor receptor | 10 |
| family flaviviridae | 10 |
| metapneumovirus infection | 10 |
| disease caused | 10 |
| soil habitat | 10 |
| ifn pathway | 10 |
| blot analysis | 10 |
| staphylococcus aureus | 10 |
| fluorescent protein | 10 |
| control study | 10 |
| sputum samples | 10 |
| iii ifn | 10 |
| body site | 10 |
| three species | 10 |
| cell lysates | 10 |
| epidemiological studies | 10 |
| healthy children | 10 |
| adv infections | 10 |
| central nervous | 10 |
| therapeutic target | 10 |
| acid sequences | 10 |
| igm antibodies | 10 |
| stat pathway | 10 |
| working concentration | 10 |
| reference genome | 10 |
| high mortality | 10 |
| intracellular trafficking | 10 |
| natural hosts | 10 |
| protease inhibitor | 10 |
| transfection reagent | 10 |
| five times | 10 |
| dominant negative | 10 |
| infected hela | 10 |
| studies suggest | 10 |
| play important | 10 |
| oligonucleotide ligation | 10 |
| ubiquitin ligases | 10 |
| phosphorylated stat | 10 |
| study also | 10 |
| infectious virus | 10 |
| mortality risk | 10 |
| infection group | 10 |
| acid sequence | 10 |
| env proteins | 10 |
| tumor virus | 10 |
| risk factor | 10 |
| studies using | 10 |
| clinical outcomes | 10 |
| copies per | 10 |
| united kingdom | 10 |
| lateral flow | 10 |
| derived peptides | 10 |
| bpv species | 10 |
| ifn responses | 10 |
| positive cells | 10 |
| better understand | 10 |
| major cause | 10 |
| aerosolized ribavirin | 10 |
| rhinovirus infections | 10 |
| normal gs | 10 |
| prophylactic effects | 10 |
| virion release | 10 |
| bacterial pneumonia | 10 |
| specific primer | 10 |
| qpcr assay | 10 |
| shed light | 10 |
| cypa overexpression | 10 |
| via clathrin | 10 |
| secondary structures | 10 |
| lamp assay | 10 |
| significantly inhibited | 10 |
| remains unknown | 10 |
| viral targets | 10 |
| viral titer | 10 |
| highly sensitive | 10 |
| bacterial species | 10 |
| glossina species | 10 |
| newly synthesized | 10 |
| food matrices | 10 |
| transplant patients | 10 |
| alveolar macrophages | 10 |
| erad process | 9 |
| endogenous retrovirus | 9 |
| clinical course | 9 |
| zikv rna | 9 |
| respiratory coronavirus | 9 |
| hypervariable region | 9 |
| antiviral role | 9 |
| two main | 9 |
| herpes zoster | 9 |
| limited number | 9 |
| related fsfs | 9 |
| pro domain | 9 |
| big data | 9 |
| transfected rk | 9 |
| serratia spp | 9 |
| kshv infection | 9 |
| expression vector | 9 |
| cells compared | 9 |
| detect viral | 9 |
| patients hospitalized | 9 |
| trypan blue | 9 |
| lytic replication | 9 |
| risk assessment | 9 |
| molecular basis | 9 |
| presenting cells | 9 |
| virology section | 9 |
| inhibit viral | 9 |
| broadly neutralizing | 9 |
| may represent | 9 |
| thank dr | 9 |
| infected vero | 9 |
| borne encephalitis | 9 |
| atypical pneumonia | 9 |
| difficile infection | 9 |
| communityacquired pneumonia | 9 |
| host protein | 9 |
| allogeneic stem | 9 |
| chronic diseases | 9 |
| hcv ns | 9 |
| signal transducer | 9 |
| volume article | 9 |
| phosphorodiamidate morpholino | 9 |
| raw data | 9 |
| cell survival | 9 |
| statistical analyses | 9 |
| cycle progression | 9 |
| iii interferon | 9 |
| hexon gene | 9 |
| mutant virus | 9 |
| will also | 9 |
| herpes virus | 9 |
| control measures | 9 |
| nucleotide identity | 9 |
| glycosylation site | 9 |
| loading control | 9 |
| tumor regression | 9 |
| pulmonary syndrome | 9 |
| rna interference | 9 |
| ighv genes | 9 |
| isgs expression | 9 |
| animal husbandry | 9 |
| murine coronavirus | 9 |
| secretory pathway | 9 |
| experimental infection | 9 |
| cancer cell | 9 |
| tyrosine kinase | 9 |
| target sequences | 9 |
| less effective | 9 |
| blood circulation | 9 |
| human endogenous | 9 |
| cell adhesion | 9 |
| kaposi sarcoma | 9 |
| considered significant | 9 |
| control groups | 9 |
| clinical manifestations | 9 |
| mulbsta score | 9 |
| antimicrobial therapy | 9 |
| upper panel | 9 |
| marburg virus | 9 |
| inhibitory concentration | 9 |
| spike glycoprotein | 9 |
| fusion occurs | 9 |
| specific treatment | 9 |
| protein assay | 9 |
| two clinical | 9 |
| based multiplex | 9 |
| environmental serratia | 9 |
| lasv hr | 9 |
| temporal dynamics | 9 |
| secondary metabolites | 9 |
| study demonstrated | 9 |
| necrosis virus | 9 |
| rapid identification | 9 |
| extracted using | 9 |
| may result | 9 |
| ph condition | 9 |
| binding interface | 9 |
| cell proteins | 9 |
| infection models | 9 |
| psap motif | 9 |
| may induce | 9 |
| ct findings | 9 |
| natural infection | 9 |
| adaptive traits | 9 |
| future studies | 9 |
| viral macro | 9 |
| study shows | 9 |
| light chain | 9 |
| human hepatoma | 9 |
| evolutionary history | 9 |
| culture supernatant | 9 |
| four major | 9 |
| blood cells | 9 |
| virome analysis | 9 |
| virus binding | 9 |
| pandemic influenza | 9 |
| lfd assay | 9 |
| analysis based | 9 |
| host specificity | 9 |
| peptide libraries | 9 |
| investigate whether | 9 |
| computational analysis | 9 |
| eukaryotic initiation | 9 |
| symptomatic patients | 9 |
| reported previously | 9 |
| bacteriophage ms | 9 |
| neutralizing activity | 9 |
| san diego | 9 |
| one hand | 9 |
| tcid assay | 9 |
| hantavirus pulmonary | 9 |
| climate seasons | 9 |
| tumor samples | 9 |
| negative results | 9 |
| fatality rate | 9 |
| hexon protein | 9 |
| hepatitis virus | 9 |
| virus particle | 9 |
| care unit | 9 |
| least two | 9 |
| disease mechanisms | 9 |
| rabbit igg | 9 |
| field conditions | 9 |
| ipd patients | 9 |
| host interaction | 9 |
| weight loss | 9 |
| ifitm protein | 9 |
| graphpad software | 9 |
| serine threonine | 9 |
| serially diluted | 9 |
| anterior kidney | 9 |
| infecting humans | 9 |
| lassa fever | 9 |
| increased mortality | 9 |
| designed based | 9 |
| read counts | 9 |
| host response | 9 |
| cytokine levels | 9 |
| host species | 9 |
| evaluated using | 9 |
| mtt assay | 9 |
| two major | 9 |
| cell penetrating | 9 |
| molecular probes | 9 |
| resistant mycoplasma | 9 |
| next generation | 9 |
| high viral | 9 |
| isolated using | 9 |
| long noncoding | 9 |
| leader protein | 9 |
| interferon signaling | 9 |
| cfus ml | 9 |
| intestinal tract | 9 |
| ex vivo | 9 |
| mcp entry | 9 |
| bacterial cells | 9 |
| also increased | 9 |
| specific protease | 9 |
| antiviral antibodies | 9 |
| hpv types | 9 |
| newly identified | 9 |
| study reported | 9 |
| using graphpad | 9 |
| unweighted unifrac | 9 |
| alexa fluor | 9 |
| protein interacts | 9 |
| thoracic society | 9 |
| rna helicase | 9 |
| goose parvovirus | 9 |
| liver cells | 9 |
| ms bacteriophage | 9 |
| experimentally infected | 9 |
| virus titers | 9 |
| syndrome caused | 9 |
| cytokine expression | 9 |
| related covs | 9 |
| nonstructural proteins | 9 |
| many studies | 9 |
| actin filaments | 9 |
| bacterial communities | 9 |
| sg proteins | 9 |
| reporter assay | 9 |
| plc prf | 9 |
| clostridium difficile | 9 |
| tested positive | 9 |
| leukemia virus | 9 |
| ns proteins | 9 |
| cellular component | 9 |
| significantly associated | 9 |
| fecal samples | 9 |
| primary antibody | 9 |
| scomber japonicus | 9 |
| signal peptide | 9 |
| binding proteins | 9 |
| inflammatory responses | 9 |
| bacillus anthracis | 9 |
| fully understood | 9 |
| immune reconstitution | 8 |
| broad spectrum | 8 |
| highly specific | 8 |
| vaccine candidates | 8 |
| post infection | 8 |
| viruses belonging | 8 |
| discovery rate | 8 |
| ebna protein | 8 |
| metapneumovirus infections | 8 |
| antiviral defense | 8 |
| climate change | 8 |
| solid organ | 8 |
| novel mammalian | 8 |
| viral life | 8 |
| prrsv lineages | 8 |
| also associated | 8 |
| insulin receptor | 8 |
| penetrating peptides | 8 |
| evolutionary dynamics | 8 |
| dna damage | 8 |
| current pandemic | 8 |
| genomic characterization | 8 |
| hr helices | 8 |
| partially sequenced | 8 |
| horizontal gene | 8 |
| atlantic salmon | 8 |
| rpv species | 8 |
| lipid membrane | 8 |
| salmonella typhimurium | 8 |
| atypical bacteria | 8 |
| lower airway | 8 |
| molecular mechanism | 8 |
| children hospitalized | 8 |
| avian coronaviruses | 8 |
| animal health | 8 |
| viral pathogen | 8 |
| glucose metabolism | 8 |
| developing countries | 8 |
| human population | 8 |
| treatment strategies | 8 |
| master mix | 8 |
| assay using | 8 |
| likelihood method | 8 |
| microbiota composition | 8 |
| like proteins | 8 |
| zinc finger | 8 |
| tm cells | 8 |
| spf chicks | 8 |
| genomic sequence | 8 |
| reduce viral | 8 |
| lung disease | 8 |
| gp protein | 8 |
| currently available | 8 |
| expression patterns | 8 |
| virus glycoprotein | 8 |
| viral nucleic | 8 |
| three biological | 8 |
| study using | 8 |
| seminiferous tubule | 8 |
| infected children | 8 |
| red blood | 8 |
| lower panel | 8 |
| receptor signaling | 8 |
| negative charges | 8 |
| phage fusion | 8 |
| cardiovascular disease | 8 |
| vertical transmission | 8 |
| plasmid dna | 8 |
| mutational analysis | 8 |
| chub mackerel | 8 |
| mouse monoclonal | 8 |
| likely due | 8 |
| hg resistance | 8 |
| hev strain | 8 |
| clinical outcome | 8 |
| phase i | 8 |
| viral panel | 8 |
| viral components | 8 |
| ms plps | 8 |
| positively correlated | 8 |
| inducible transmembrane | 8 |
| positive patients | 8 |
| guangxi province | 8 |
| isg expression | 8 |
| surface antigen | 8 |
| detailed information | 8 |
| alpha diversity | 8 |
| safe working | 8 |
| structural biology | 8 |
| tbk phosphorylation | 8 |
| kg sab | 8 |
| protein level | 8 |
| antibiotic resistant | 8 |
| case fatality | 8 |
| erad pathway | 8 |
| armored rna | 8 |
| differential expression | 8 |
| corresponding author | 8 |
| signaling lymphocyte | 8 |
| deficient mice | 8 |
| nile river | 8 |
| virus research | 8 |
| sar strain | 8 |
| hrv infections | 8 |
| following pr | 8 |
| takes place | 8 |
| porcine intestinal | 8 |
| drop syndrome | 8 |
| positive cases | 8 |
| human rhinoviruses | 8 |
| bacterial pathogen | 8 |
| single copy | 8 |
| chicken ifitm | 8 |
| induce apoptosis | 8 |
| green fluorescent | 8 |
| family hepeviridae | 8 |
| monkey kidney | 8 |
| candidatus arthromitus | 8 |
| three replicates | 8 |
| replication cycle | 8 |
| complex glycans | 8 |
| functional analysis | 8 |
| target protein | 8 |
| washed twice | 8 |
| relative expression | 8 |
| bacterial load | 8 |
| also inhibit | 8 |
| therapeutic approaches | 8 |
| cerebrospinal fluid | 8 |
| somatic mutations | 8 |
| sfb genomes | 8 |
| prrsv infection | 8 |
| murine norovirus | 8 |
| evolutionary genetics | 8 |
| pcr using | 8 |
| previous report | 8 |
| direct interaction | 8 |
| host immunity | 8 |
| avian hev | 8 |
| substrate binding | 8 |
| kshv rta | 8 |
| signaling events | 8 |
| sarcomaassociated herpesvirus | 8 |
| evolutionary relationships | 8 |
| viral diversity | 8 |
| previously demonstrated | 8 |
| type diabetes | 8 |
| igf expression | 8 |
| multiple respiratory | 8 |
| factor alpha | 8 |
| th cell | 8 |
| acid extraction | 8 |
| fusion peptide | 8 |
| purifying selection | 8 |
| plant growth | 8 |
| commensal bacteria | 8 |
| mini kit | 8 |
| human body | 8 |
| secreted ns | 8 |
| lung epithelial | 8 |
| dependent signaling | 8 |
| blood flukes | 8 |
| egr plasmids | 8 |
| fruit bats | 8 |
| scale bar | 8 |
| envelope proteins | 8 |
| vero cell | 8 |
| correlated positively | 8 |
| cells harboring | 8 |
| penetrating peptide | 8 |
| sterile pbs | 8 |
| secondary infections | 8 |
| ct method | 8 |
| neuropathic pain | 8 |
| raw reads | 8 |
| coding gene | 8 |
| genome encodes | 8 |
| ip assay | 8 |
| viral hepatitis | 8 |
| hbga binding | 8 |
| quantitative proteomic | 8 |
| renal syndrome | 8 |
| helicase domain | 8 |
| like particle | 8 |
| three groups | 8 |
| genome analysis | 8 |
| may allow | 8 |
| also significantly | 8 |
| cypa expression | 8 |
| protein disulfide | 8 |
| rna samples | 8 |
| flying fox | 8 |
| viral genomic | 8 |
| interferon lambda | 8 |
| conjugated pmo | 8 |
| protein glycosylation | 8 |
| evolutionary rates | 8 |
| fluorescently labeled | 8 |
| disulfide isomerase | 8 |
| showed high | 8 |
| hydrogen peroxide | 8 |
| positive selective | 8 |
| virus interacts | 8 |
| density levels | 8 |
| membrane proteins | 8 |
| bacterial genera | 8 |
| vp vp | 8 |
| lymphocyte activation | 8 |
| first time | 8 |
| cause disease | 8 |
| mice lacking | 8 |
| viral species | 8 |
| prolonged shedding | 8 |
| may occur | 8 |
| ar spread | 8 |
| neonatal piglets | 8 |
| viral populations | 8 |
| bacterial infection | 8 |
| samples collected | 8 |
| subgenomic rna | 8 |
| expression plasmids | 8 |
| proinflammatory cytokines | 8 |
| cell type | 8 |
| culture methods | 8 |
| ace receptor | 8 |
| entry site | 8 |
| recent reports | 8 |
| constructed using | 8 |
| repeated three | 8 |
| proteins identified | 8 |
| orf ab | 8 |
| kda protein | 8 |
| ex taq | 8 |
| viral persistence | 8 |
| ifitm restriction | 8 |
| surface expression | 8 |
| lb broth | 8 |
| host responses | 8 |
| life sciences | 8 |
| infected chicks | 8 |
| yersinia pestis | 8 |
| dmem supplemented | 8 |
| high specificity | 8 |
| past years | 8 |
| medical sciences | 8 |
| tag sequence | 8 |
| confocal microscopy | 8 |
| using real | 8 |
| retrotranscribing viruses | 8 |
| haemorrhagic disease | 8 |
| rabbit haemorrhagic | 8 |
| also evaluated | 8 |
| candida albicans | 8 |
| infectious entry | 8 |
| virus human | 8 |
| another group | 8 |
| cell tropism | 8 |
| east asia | 8 |
| human lung | 8 |
| nc sirna | 8 |
| rav positions | 8 |
| significant reduction | 8 |
| cell metabolic | 8 |
| gene source | 8 |
| recently emerged | 8 |
| tracker orange | 8 |
| cell tracker | 8 |
| treated group | 8 |
| spleen samples | 8 |
| therapeutic drugs | 8 |
| type system | 8 |
| bat coronaviruses | 8 |
| cytopathic effects | 8 |
| animal species | 8 |
| transmission electron | 8 |
| weighted unifrac | 8 |
| negative bacteria | 8 |
| decreased significantly | 8 |
| acute gastroenteritis | 8 |
| like cells | 8 |
| survival rate | 8 |
| clinically relevant | 8 |
| life cycles | 8 |
| significantly upregulated | 8 |
| cellular proliferation | 8 |
| lymphocyte count | 8 |
| primers used | 8 |
| serine protease | 8 |
| airway remodeling | 8 |
| type lectin | 8 |
| densitometric analysis | 8 |
| also decreased | 8 |
| article supplementary | 8 |
| endemic areas | 8 |
| pattern recognition | 8 |
| van houten | 8 |
| significantly altered | 8 |
| north american | 8 |
| high quality | 8 |
| murine leukemia | 8 |
| pathogen interactions | 8 |
| airway inflammation | 8 |
| per well | 8 |
| immunocompromised patients | 8 |
| immune modulation | 8 |
| studies demonstrated | 8 |
| cdna synthesis | 8 |
| egr expression | 8 |
| newcastle disease | 8 |
| specific phage | 8 |
| psvna titers | 8 |
| natural killer | 8 |
| start site | 8 |
| cells seeded | 8 |
| asthmatic subjects | 8 |
| time quantitative | 8 |
| escape ifn | 8 |
| polyacrylamide gel | 7 |
| sample collection | 7 |
| genus pestivirus | 7 |
| interaction network | 7 |
| severe bronchiolitis | 7 |
| human enterovirus | 7 |
| one patient | 7 |
| rodent species | 7 |
| overexpressed cells | 7 |
| red list | 7 |
| protein complex | 7 |
| protein structure | 7 |
| virus inhibits | 7 |
| infection status | 7 |
| transcription polymerase | 7 |
| expression system | 7 |
| orf encodes | 7 |
| fluorescent reporter | 7 |
| clinical practice | 7 |
| virus vaccine | 7 |
| ns hexamer | 7 |
| wild boar | 7 |
| synthetic peptides | 7 |
| still unknown | 7 |
| indel strain | 7 |
| fluorescence microscopy | 7 |
| pf emp | 7 |
| medicinal plants | 7 |
| transmembrane domains | 7 |
| prepared ms | 7 |
| dead patients | 7 |
| antigen presenting | 7 |
| structure analysis | 7 |
| mouse mammary | 7 |
| protein forms | 7 |
| bacterial diversity | 7 |
| viruses detected | 7 |
| ebv replication | 7 |
| highly diverse | 7 |
| scientific community | 7 |
| medical research | 7 |
| rna levels | 7 |
| specific viral | 7 |
| restriction factor | 7 |
| duchenne muscular | 7 |
| molecular methods | 7 |
| pcr method | 7 |
| realtime pcr | 7 |
| molecular diagnosis | 7 |
| indel pedv | 7 |
| clinical utility | 7 |
| worth mentioning | 7 |
| viral rnas | 7 |
| fixation test | 7 |
| accessory proteins | 7 |
| rhdv nsp | 7 |
| cell cytoplasm | 7 |
| also tested | 7 |
| transcription unit | 7 |
| human papilloma | 7 |
| virus induces | 7 |
| one representative | 7 |
| long non | 7 |
| different levels | 7 |
| tandem mass | 7 |
| egr knockdown | 7 |
| lentiviruses expressing | 7 |
| nucleolar proteins | 7 |
| singapore grouper | 7 |
| swine acute | 7 |
| pedv strain | 7 |
| virus assembly | 7 |
| etiological agent | 7 |
| lymphocyte counts | 7 |
| rheumatoid arthritis | 7 |
| dna binding | 7 |
| structural characterization | 7 |
| increased expression | 7 |
| left panel | 7 |
| bat genomes | 7 |
| genome using | 7 |
| phosphate buffered | 7 |
| seeded onto | 7 |
| rpoa gene | 7 |
| microbiology virology | 7 |
| hcv genome | 7 |
| sample size | 7 |
| well tolerated | 7 |
| los santos | 7 |
| potential use | 7 |
| response element | 7 |
| endocytotic pathway | 7 |
| negative mutant | 7 |
| pv sax | 7 |
| species transmission | 7 |
| beta production | 7 |
| suppressed fmdv | 7 |
| cells per | 7 |
| treatment options | 7 |
| genbank database | 7 |
| young adults | 7 |
| biotechnology information | 7 |
| section materials | 7 |
| alignment tool | 7 |
| phosphate dehydrogenase | 7 |
| viruses exploit | 7 |
| analysis skills | 7 |
| right panel | 7 |
| deep sequencing | 7 |
| treatment plants | 7 |
| illumina sequencing | 7 |
| cells ml | 7 |
| huh cells | 7 |
| fluorescence microscope | 7 |
| severe clinical | 7 |
| classical swine | 7 |
| national research | 7 |
| genome coverage | 7 |
| virus genotypes | 7 |
| cellular components | 7 |
| various types | 7 |
| signal inside | 7 |
| four genotypes | 7 |
| org article | 7 |
| eaton agent | 7 |
| detection rates | 7 |
| beta interferon | 7 |
| genotype hepatitis | 7 |
| comparative genomics | 7 |
| snp rs | 7 |
| thunnus maccoyii | 7 |
| venezuelan equine | 7 |
| equal amounts | 7 |
| premix ex | 7 |
| respiratory pathogen | 7 |
| proteins detected | 7 |
| cell interactions | 7 |
| microplate reader | 7 |
| coding rnas | 7 |
| study provides | 7 |
| genetics analysis | 7 |
| infections may | 7 |
| interferon induction | 7 |
| marine fish | 7 |
| entry process | 7 |
| protein binding | 7 |
| gpc protein | 7 |
| recombinant protein | 7 |
| core associated | 7 |
| ribavirin treatment | 7 |
| green monkey | 7 |
| ns protease | 7 |
| pel cells | 7 |
| aa residues | 7 |
| sequencing reads | 7 |
| lytic cycle | 7 |
| isg genes | 7 |
| icbi vigen | 7 |
| viral translation | 7 |
| closest taxonomic | 7 |
| effective antiviral | 7 |
| protein inhibits | 7 |
| prd adenovirus | 7 |
| muscular dystrophy | 7 |
| rana box | 7 |
| higher expression | 7 |
| elisa kit | 7 |
| human tumor | 7 |
| fatty acids | 7 |
| higher risk | 7 |
| coronavirus infectious | 7 |
| direct binding | 7 |
| data show | 7 |
| pneumococcal disease | 7 |
| generation sequencers | 7 |
| complement fixation | 7 |
| extracellular supernatants | 7 |
| fusion pores | 7 |
| coding sequence | 7 |
| also important | 7 |
| cruise ship | 7 |
| semliki forest | 7 |
| pacific chub | 7 |
| gastrointestinal pathogen | 7 |
| porcine kidney | 7 |
| also demonstrated | 7 |
| viral strains | 7 |
| common cause | 7 |
| luminex xmap | 7 |
| also used | 7 |
| lipid droplets | 7 |
| site year | 7 |
| virus among | 7 |
| predicted using | 7 |
| family proteins | 7 |
| response gene | 7 |
| csa treatment | 7 |
| scop relatives | 7 |
| proteolytic cleavage | 7 |
| protein phosphatase | 7 |
| current status | 7 |
| genetic variation | 7 |
| persistent lcmv | 7 |
| virion surface | 7 |
| primary antibodies | 7 |
| dimethyl sulfoxide | 7 |
| gene annotation | 7 |
| replication complex | 7 |
| protease domain | 7 |
| outer membrane | 7 |
| treated zikv | 7 |
| transmitted via | 7 |
| escape mutants | 7 |
| bacterial composition | 7 |
| regulatory protein | 7 |
| modified bovine | 7 |
| rna copies | 7 |
| high sensitivity | 7 |
| risk groups | 7 |
| aligned using | 7 |
| infections among | 7 |
| phylogenetic analyses | 7 |
| invasive pneumococcal | 7 |
| protein interactions | 7 |
| hepatoma cell | 7 |
| resistance determinants | 7 |
| base pairs | 7 |
| unfolded proteins | 7 |
| acute exacerbations | 7 |
| lipid metabolism | 7 |
| disease pathogenesis | 7 |
| results revealed | 7 |
| using imagej | 7 |
| assay formats | 7 |
| tumor suppressor | 7 |
| glycan structures | 7 |
| subcellular distribution | 7 |
| paired sera | 7 |
| requires endocytosis | 7 |
| heptad repeat | 7 |
| immunoblot analysis | 7 |
| high concentrations | 7 |
| positive granules | 7 |
| molecular function | 7 |
| developed countries | 7 |
| enteric viruses | 7 |
| clinical significance | 7 |
| read depth | 7 |
| study revealed | 7 |
| infection also | 7 |
| immunofluorescence assay | 7 |
| carcinoma cells | 7 |
| indicated times | 7 |
| strongly associated | 7 |
| strains isolated | 7 |
| coding regions | 7 |
| studies indicate | 7 |
| culture medium | 7 |
| also suggested | 7 |
| fatty acid | 7 |
| rich domain | 7 |
| tracheal epithelial | 7 |
| yellowtail kingfish | 7 |
| cycle arrest | 7 |
| consensus sequence | 7 |
| serological tests | 7 |
| case studies | 7 |
| protein alone | 7 |
| mutant viruses | 7 |
| protein folds | 7 |
| syncytial viruses | 7 |
| clinical use | 7 |
| confirmed cases | 7 |
| sequenced using | 7 |
| technical assistance | 7 |
| including influenza | 7 |
| made available | 7 |
| mammary tumor | 7 |
| reverse transcribed | 7 |
| wound healing | 7 |
| genus alphacoronavirus | 7 |
| sfb colonization | 7 |
| common pathogens | 7 |
| ms coat | 7 |
| method using | 7 |
| latent infection | 7 |
| cell function | 7 |
| mice infected | 7 |
| fish mucosal | 7 |
| contains two | 7 |
| genotype database | 7 |
| novel lncrnas | 7 |
| french polynesia | 7 |
| rna helicases | 7 |
| chikungunya virus | 7 |
| human viruses | 7 |
| derived cells | 7 |
| prevent zikv | 7 |
| equine encephalitis | 7 |
| pneumonia patients | 7 |
| isolated rna | 7 |
| median age | 7 |
| geographical distribution | 7 |
| antiviral compounds | 7 |
| novel virus | 7 |
| plex assay | 7 |
| opportunistic pathogens | 7 |
| human participants | 7 |
| diagnostic tests | 7 |
| clinical isolates | 7 |
| untreated cells | 7 |
| complement activation | 7 |
| leuconostoc mesenteroides | 7 |
| cells showed | 7 |
| coding region | 7 |
| dengue viruses | 7 |
| lasv gpc | 7 |
| river cruise | 7 |
| daily average | 7 |
| polarized epithelial | 7 |
| atypical porcine | 7 |
| ion channels | 7 |
| authors reviewed | 7 |
| ifn response | 7 |
| postherpetic neuralgia | 7 |
| may affect | 7 |
| protein gene | 7 |
| signaling cascade | 7 |
| statistical software | 7 |
| human ifitm | 7 |
| novel host | 7 |
| macro domains | 7 |
| observational study | 7 |
| hr peptide | 7 |
| cypa depletion | 7 |
| virus lower | 7 |
| avian ifitm | 7 |
| hydrophilic interactions | 7 |
| protein activates | 7 |
| np cd | 7 |
| autophagosome formation | 7 |
| cytokine responses | 7 |
| elevated levels | 7 |
| mouse models | 7 |
| viral proliferation | 7 |
| imagej software | 7 |
| inhibit hpv | 7 |
| takara bio | 7 |
| individual health | 7 |
| cardiovirus infection | 7 |
| human milk | 7 |
| apoptosis induced | 7 |
| cellular membranes | 7 |
| bat cov | 7 |
| amplification assay | 7 |
| health services | 7 |
| allowed us | 7 |
| endophytic actinomycetes | 7 |
| vaccine development | 7 |
| much higher | 7 |
| molecular detection | 7 |
| pteropus bat | 7 |
| novel human | 7 |
| standard curve | 7 |
| induce ifn | 7 |
| detection methods | 7 |
| replication level | 7 |
| intestinal epithelium | 7 |
| severe pneumonia | 7 |
| effusion lymphoma | 7 |
| gc content | 7 |
| illumina hiseq | 7 |
| gfp expression | 7 |
| result showed | 7 |
| national institute | 7 |
| orange dots | 7 |
| rdrp region | 7 |
| stool samples | 7 |
| cards toxin | 7 |
| infected human | 7 |
| polyubiquitin chains | 7 |
| magnetic beads | 7 |
| cytokine production | 7 |
| samples using | 7 |
| nk cells | 7 |
| mitochondrial dna | 7 |
| genetic variability | 7 |
| experiments indicate | 7 |
| sirna targeting | 7 |
| newborn piglets | 7 |
| entry inhibitor | 7 |
| diseases society | 7 |
| bat sars | 7 |
| false discovery | 7 |
| relative abundance | 7 |
| viruses associated | 7 |
| vp gene | 7 |
| cleavage sites | 7 |
| pcr assays | 7 |
| primer pairs | 7 |
| survival time | 7 |
| viral lineage | 7 |
| different concentration | 7 |
| com icbi | 7 |
| biological significance | 7 |
| economic impact | 7 |
| phage dna | 7 |
| hospital stay | 7 |
| sm buffer | 7 |
| pcr primers | 7 |
| chronic hev | 7 |
| previous work | 7 |
| clostridioides difficile | 7 |
| heat map | 7 |
| serial dilutions | 7 |
| cell plasma | 7 |
| fold dilution | 7 |
| adenovirus dna | 7 |
| different ecosystems | 7 |
| iucn red | 7 |
| pcr detection | 7 |
| related proteins | 7 |
| recent research | 7 |
| primary human | 7 |
| neutralizing monoclonal | 7 |
| ecoplates tm | 7 |
| infection causes | 7 |
| molecular characterization | 7 |
| microbiome studies | 7 |
| cellular functions | 7 |
| poorly understood | 7 |
| mechanical ventilation | 7 |
| animal study | 7 |
| net negative | 7 |
| sindbis virus | 6 |
| bronchoalveolar lavage | 6 |
| acute lower | 6 |
| bacterial dna | 6 |
| major histocompatibility | 6 |
| yunnan province | 6 |
| mer operon | 6 |
| bacterial culture | 6 |
| cell epitopes | 6 |
| modified eagle | 6 |
| like symptoms | 6 |
| study suggested | 6 |
| microsphere surface | 6 |
| antiviral protein | 6 |
| infected male | 6 |
| small number | 6 |
| fusion proteins | 6 |
| higher bacterial | 6 |
| receptor recognition | 6 |
| based drug | 6 |
| hev pcp | 6 |
| binding lectin | 6 |
| critically ill | 6 |
| nucleotide polymorphism | 6 |
| trs motif | 6 |
| matrix metalloproteinase | 6 |
| control strategies | 6 |
| higher proportion | 6 |
| virus activates | 6 |
| antibiotic consumption | 6 |
| based assay | 6 |
| different viral | 6 |
| genus betacoronavirus | 6 |
| mediated il | 6 |
| material section | 6 |
| applied hp | 6 |
| alive patients | 6 |
| vp coding | 6 |
| using lipofectamine | 6 |
| phosphorodiamidate linkages | 6 |
| landscape phage | 6 |
| sgivinfected cells | 6 |
| different proteins | 6 |
| primary effusion | 6 |
| variation among | 6 |
| persistently infected | 6 |
| american type | 6 |
| divergence times | 6 |
| virus vp | 6 |
| isolated strains | 6 |
| economic development | 6 |
| disease burden | 6 |
| much less | 6 |
| mev infection | 6 |
| mainly causes | 6 |
| genome evolution | 6 |
| different viruses | 6 |
| ypk possessed | 6 |
| orf proteins | 6 |
| virus production | 6 |
| gene encoding | 6 |
| plant species | 6 |
| cecum tissue | 6 |
| purified using | 6 |
| side effects | 6 |
| pam cells | 6 |
| associated gene | 6 |
| food animals | 6 |
| two experiments | 6 |
| fully human | 6 |
| mshmp sequences | 6 |
| immune function | 6 |
| virus may | 6 |
| microbiome samples | 6 |
| antimicrobial agents | 6 |
| isre luciferase | 6 |
| parasite infection | 6 |
| phage coat | 6 |
| igf plays | 6 |
| multiple viral | 6 |
| late infection | 6 |
| suckling piglets | 6 |
| infection among | 6 |
| science foundation | 6 |
| step growth | 6 |
| conducted using | 6 |
| andmouth disease | 6 |
| rhinolophus bats | 6 |
| human embryonic | 6 |
| phage particles | 6 |
| viral disease | 6 |
| healthy adults | 6 |
| viral families | 6 |
| quantified using | 6 |
| crucial role | 6 |
| immune status | 6 |
| spectrum antiviral | 6 |
| among others | 6 |
| anal swab | 6 |
| organ failure | 6 |
| shock protein | 6 |
| bronchial epithelial | 6 |
| endemic regions | 6 |
| multiple alignment | 6 |
| lymphoid tissues | 6 |
| clinical disease | 6 |
| ribosomal rna | 6 |
| amplification techniques | 6 |
| potential risk | 6 |
| malaria endemicity | 6 |
| muscovy duck | 6 |
| endogenous ifn | 6 |
| mechanisms involved | 6 |
| rhesus macaque | 6 |
| ultrastructural localization | 6 |
| high concentration | 6 |
| using standard | 6 |
| new viruses | 6 |
| bioactive metabolites | 6 |
| inhibitors targeting | 6 |
| whether pedv | 6 |
| nasopharyngeal swabs | 6 |
| contact surfaces | 6 |
| final version | 6 |
| investigated whether | 6 |
| future prospects | 6 |
| study found | 6 |
| intracellular signaling | 6 |
| structural similarities | 6 |
| cardicola forsteri | 6 |
| evolutionary analyses | 6 |
| pmo target | 6 |
| drug repurposing | 6 |
| downstream signaling | 6 |
| nuclear pore | 6 |
| two case | 6 |
| displayed peptides | 6 |
| commercial vaccines | 6 |
| pharmajet stratis | 6 |
| culture collection | 6 |
| chlamydia pneumoniae | 6 |
| recent evidence | 6 |
| research council | 6 |
| pathogens detected | 6 |
| animal experiments | 6 |
| cell contact | 6 |
| kinase pkr | 6 |
| protein may | 6 |
| caenorhabditis elegans | 6 |
| current work | 6 |
| antiviral proteins | 6 |
| using quantitative | 6 |